相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized study combining interferon and glatiramer acetate in multiple sclerosis
Fred D. Lublin et al.
ANNALS OF NEUROLOGY (2013)
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
John Zajicek et al.
LANCET NEUROLOGY (2013)
Timed 25-Foot Walk Direct evidence that improving 20% or greater is clinically meaningful in MS
Jeremy Hobart et al.
NEUROLOGY (2013)
The Critical Path Initiative: Leveraging Collaborations to Enhance Regulatory Science
R. A. Barratt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Jeffrey A. Cohen et al.
LANCET (2012)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Alasdair J. Coles et al.
LANCET (2012)
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
Jeffrey A. Cohen et al.
LANCET NEUROLOGY (2012)
Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures
D. Ontaneda et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis Five-Year Clinical Trial Follow-up
Carmen Tur et al.
ARCHIVES OF NEUROLOGY (2011)
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
M. S. Freedman et al.
NEUROLOGY (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Phase 3 Trial of Extended Release Oral Dalfampridine in Multiple Sclerosis
Andrew D. Goodman et al.
ANNALS OF NEUROLOGY (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. (vol 9, pg 381, 2010)
D. Wynn et al.
LANCET NEUROLOGY (2010)
Younger children with MS have a distinct CSF inflammatory profile at disease onset
D. Chabas et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
Daniel Wynn et al.
LANCET NEUROLOGY (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
The multiple sclerosis severity score (MSSS) predicts disease severity over time
Andrew R. Pachner et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS
J. A. Cohen et al.
NEUROLOGY (2009)
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
L. J. Balcer et al.
NEUROLOGY (2007)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis
ML Baier et al.
NEUROLOGY (2005)
A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS
M Clanet et al.
NEUROLOGY (2002)
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen et al.
NEUROLOGY (2002)
分享论文
